Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Excessive androgens in women with polycystic ovary syndrome can lead to excessive hair growth and hair loss, but this might not fully explain these conditions.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Adiponectin reduces inflammation and bone loss in joint replacements.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Natural products may help treat skin inflammation from abnormal adrenal hormones.